Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Med Genet A ; : e63647, 2024 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-38877820

RESUMEN

Harel-Yoon syndrome (HAYOS) is a unique neurodevelopmental genetic disorder characterized by hypotonia, spasticity, intellectual disability, hypertrophic cardiomyopathy, and global developmental delay. It primarily results from mutations in the ATAD3A gene, pivotal for mitochondrial function. This report presents a 5-year-old girl with HAYOS harboring a de novo heterozygous variant c.1064G>A; (p.G355D) in ATAD3A. Her clinical profile includes delayed milestones, hypotonia, spastic quadriplegia, and ptosis. Notably, dermatologic anomalies such as hypopigmentation, café au lait macules, and freckling are observed, expanding the known phenotype of HAYOS. The inclusion of dermatologic features challenges our understanding of the syndrome and emphasizes the importance of further research to elucidate the molecular connections between ATAD3A mutations and dermatologic manifestations.

2.
Arterioscler Thromb Vasc Biol ; 36(7): 1350-5, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27199446

RESUMEN

OBJECTIVE: We recently identified a locus on chromosome 18q11.2 for high serum triglycerides in Mexicans. We hypothesize that the lead genome-wide association study single-nucleotide polymorphism rs9949617, or its linkage disequilibrium proxies, regulates 1 of the 5 genes in the triglyceride-associated region. APPROACH AND RESULTS: We performed a linkage disequilibrium analysis and found 9 additional variants in linkage disequilibrium (r(2)>0.7) with the lead single-nucleotide polymorphism. To select the variants for functional analyses, we annotated the 10 variants using DNase I hypersensitive sites, transcription factor and chromatin states and identified rs17259126 as the lead candidate variant for functional in vitro validation. Using luciferase transcriptional reporter assay in liver HepG2 cells, we found that the G allele exhibits a significantly lower effect on transcription (P<0.05). The electrophoretic mobility shift and ChIPqPCR (chromatin immunoprecipitation coupled with quantitative polymerase chain reaction) assays confirmed that the minor G allele of rs17259126 disrupts an hepatocyte nuclear factor 4 α-binding site. To find the regional candidate gene, we performed a local expression quantitative trait locus analysis and found that rs17259126 and its linkage disequilibrium proxies alter expression of the regional transmembrane protein 241 (TMEM241) gene in 795 adipose RNAs from the Metabolic Syndrome In Men (METSIM) cohort (P=6.11×10(-07)-5.80×10(-04)). These results were replicated in expression profiles of TMEM241 from the Multiple Tissue Human Expression Resource (MuTHER; n=856). CONCLUSIONS: The Mexican genome-wide association study signal for high serum triglycerides on chromosome 18q11.2 harbors a regulatory single-nucleotide polymorphism, rs17259126, which disrupts normal hepatocyte nuclear factor 4 α binding and decreases the expression of the regional TMEM241 gene. Our data suggest that decreased transcript levels of TMEM241 contribute to increased triglyceride levels in Mexicans.


Asunto(s)
Cromosomas Humanos Par 18 , Factor Nuclear 4 del Hepatocito/genética , Metabolismo de los Lípidos/genética , Proteínas de la Membrana/genética , Polimorfismo de Nucleótido Simple , Triglicéridos/sangre , Anciano , Sitios de Unión , Finlandia , Genes Reporteros , Marcadores Genéticos , Estudio de Asociación del Genoma Completo , Genotipo , Células Hep G2 , Factor Nuclear 4 del Hepatocito/metabolismo , Humanos , Desequilibrio de Ligamiento , Masculino , Proteínas de la Membrana/metabolismo , México , Persona de Mediana Edad , Fenotipo , Sitios de Carácter Cuantitativo , Transcripción Genética , Transfección , Estados Unidos , Regulación hacia Arriba
3.
Stroke ; 46(9): 2445-51, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26251247

RESUMEN

BACKGROUND AND PURPOSE: Remote ischemic conditioning (RIC) is a phenomenon in which short periods of nonfatal ischemia in 1 tissue confers protection to distant tissues. Here we performed a longitudinal human pilot study in patients with aneurysmal subarachnoid hemorrhage undergoing RIC by limb ischemia to compare changes in DNA methylation and transcriptome profiles before and after RIC. METHODS: Thirteen patients underwent 4 RIC sessions over 2 to 12 days after rupture of an intracranial aneurysm. We analyzed whole blood transcriptomes using RNA sequencing and genome-wide DNA methylomes using reduced representation bisulfite sequencing, both before and after RIC. We tested differential expression and differential methylation using an intraindividual paired study design and then overlapped the differential expression and differential methylation results for analyses of functional categories and protein-protein interactions. RESULTS: We observed 164 differential expression genes and 3493 differential methylation CpG sites after RIC, of which 204 CpG sites overlapped with 103 genes, enriched for pathways of cell cycle (P<3.8×10(-4)) and inflammatory responses (P<1.4×10(-4)). The cell cycle pathway genes form a significant protein-protein interaction network of tightly coexpressed genes (P<0.00001). CONCLUSIONS: Gene expression and DNA methylation changes in aneurysmal subarachnoid hemorrhage patients undergoing RIC are involved in coordinated cell cycle and inflammatory responses.


Asunto(s)
Metilación de ADN/fisiología , Expresión Génica/fisiología , Genes cdc/fisiología , Aneurisma Intracraneal/metabolismo , Precondicionamiento Isquémico/métodos , Hemorragia Subaracnoidea/metabolismo , Adulto , Anciano , Femenino , Humanos , Aneurisma Intracraneal/terapia , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Proyectos Piloto , Hemorragia Subaracnoidea/terapia , Transcriptoma/fisiología
4.
J Med Genet ; 50(5): 298-308, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23505323

RESUMEN

BACKGROUND: The Mexican population and others with Amerindian heritage exhibit a substantial predisposition to dyslipidemias and coronary heart disease. Yet, these populations remain underinvestigated by genomic studies, and to date, no genome-wide association (GWA) studies have been reported for lipids in these rapidly expanding populations. METHODS AND FINDINGS: We performed a two-stage GWA study for hypertriglyceridemia and low high-density lipoprotein cholesterol (HDL-C) in Mexicans (n=4361), and identified a novel Mexican-specific genome-wide significant locus for serum triglycerides (TGs) near the Niemann-Pick type C1 protein gene (p=2.43×10(-08)). Furthermore, three European loci for TGs (APOA5, GCKR and LPL), and four loci for HDL-C (ABCA1, CETP, LIPC and LOC55908) reached genome-wide significance in Mexicans. We used cross-ethnic mapping to narrow three European TG GWA loci, APOA5, MLXIPL, and CILP2 that were wide and contained multiple candidate variants in the European scan. At the APOA5 locus, this reduced the most likely susceptibility variants to one, rs964184. Importantly, our functional analysis demonstrated a direct link between rs964184 and postprandial serum apoAV protein levels, supporting rs964184 as the causative variant underlying the European and Mexican GWA signal. Overall, 52 of the 100 reported associations from European lipid GWA meta-analysis generalised to Mexicans. However, in 82 of the 100 European GWA loci, a different variant other than the European lead/best-proxy variant had the strongest regional evidence of association in Mexicans. CONCLUSIONS: This first Mexican GWA study of lipids identified a novel GWA locus for high TG levels; used the interpopulation heterogeneity to significantly restrict three previously known European GWA signals, and surveyed whether the European lipid GWA SNPs extend to the Mexican population.


Asunto(s)
Apolipoproteínas A/genética , Sitios Genéticos/genética , Hipertrigliceridemia/genética , Hipoalfalipoproteinemias/genética , Indígenas Norteamericanos/genética , Triglicéridos/genética , Apolipoproteína A-V , Apolipoproteínas A/sangre , Estudio de Asociación del Genoma Completo , Genotipo , Humanos , Hipertrigliceridemia/etnología , Hipoalfalipoproteinemias/etnología , Desequilibrio de Ligamiento , Proteínas de la Membrana/genética , Proteínas de Transporte de Membrana , México , Polimorfismo de Nucleótido Simple/genética , Triglicéridos/sangre , Población Blanca/genética
5.
Arterioscler Thromb Vasc Biol ; 32(5): 1204-10, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22345169

RESUMEN

OBJECTIVE: Lipoprotein lipase (LPL) is a principal enzyme in lipoprotein metabolism, tissue lipid utilization, and energy metabolism. LPL is synthesized by parenchymal cells in adipose, heart, and muscle tissues followed by secretion to extracellular sites, where lipolyic function is exerted. The catalytic activity of LPL is attained during posttranslational maturation, which involves glycosylation, folding, and subunit assembly within the endoplasmic reticulum. A lipase-chaperone, lipase maturation factor 1 (Lmf1), has recently emerged as a critical factor in this process. Previous studies demonstrated that loss-of-function mutations of Lmf1 result in diminished lipase activity and severe hypertriglyceridemia in mice and human subjects. The objective of this study is to investigate whether, beyond its role as a required factor in lipase maturation, variation in Lmf1 expression is sufficient to modulate LPL activity in vivo. METHODS AND RESULTS: To assess the effects of Lmf1 overexpression in adipose and muscle tissues, we generated aP2-Lmf1 and Mck-Lmf1 transgenic mice. Characterization of relevant tissues revealed increased LPL activity in both mouse strains. In the omental and subcutaneous adipose depots, Lmf1 overexpression was associated with increased LPL specific activity without changes in LPL mass. In contrast, increased LPL activity was due to elevated LPL protein level in heart and gonadal adipose tissue. To extend these studies to humans, we detected association between LMF1 gene variants and postheparin LPL activity in a dyslipidemic cohort. CONCLUSIONS: Our results suggest that variation in Lmf1 expression is a posttranslational determinant of LPL activity.


Asunto(s)
ADN/genética , Metabolismo Energético/fisiología , Regulación de la Expresión Génica , Variación Genética , Hipertrigliceridemia/genética , Lipoproteína Lipasa/genética , Proteínas de la Membrana/genética , Tejido Adiposo/metabolismo , Animales , Humanos , Hipertrigliceridemia/metabolismo , Lipoproteína Lipasa/biosíntesis , Proteínas de la Membrana/biosíntesis , Ratones , Ratones Transgénicos , Músculo Esquelético/metabolismo , Miocardio/metabolismo
6.
Arterioscler Thromb Vasc Biol ; 31(5): 1201-7, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21393584

RESUMEN

OBJECTIVE: Recent genome-wide association studies identified a variant rs7575840 in the apolipoprotein B (APOB) gene region as associated with low-density lipoprotein (LDL) cholesterol. However, the underlying functional mechanism of this variant, which resides 6.5 kb upstream of APOB, has remained unknown. Our objective was to investigate rs7575840 for association with refined apoB-containing lipid particles, for replication in a Mexican population, and for its underlying functional mechanism. METHODS AND RESULTS: Our data show that rs7575840 is associated with serum apoB levels (P=4.85×10(-10)) and apoB-containing lipid particles, very small very-low-density lipoprotein, intermediate lipoprotein, and LDL particles (P=2×10(-5) to 9×10(-7)) in the Finnish Metabolic Syndrome in Men study sample (n=7710). Fine mapping of the APOB region using 43 single-nucleotide polymorphisms replicated the association of rs7575840 with apoB in a Mexican study sample (n=2666, P=3.33×10(-5)). Furthermore, our transcript analyses of adipose RNA samples from 175 subjects in the Finnish Metabolic Syndrome in Men study indicate that rs7575840 alters expression of APOB (P=1.13×10(-10)) and a regional noncoding RNA (BU630349) (P=7.86×10(-6)) in adipose tissue. CONCLUSIONS: It has been difficult to convert genome-wide association study associations into mechanistic insights. Our data show that rs7575840 is associated with serum apoB levels and apoB-containing lipid particles, as well as influencing expression of APOB and a regional transcript BU630349 in adipose tissue. We thus provide evidence how a common genome-wide significant single-nucleotide polymorphism, rs7575840, may affect serum apoB, LDL cholesterol, and total cholesterol levels.


Asunto(s)
Apolipoproteínas B/genética , Hipertrigliceridemia/genética , Polimorfismo de Nucleótido Simple , Tejido Adiposo/metabolismo , Anciano , Apolipoproteínas B/sangre , Biomarcadores/sangre , Estudios de Casos y Controles , LDL-Colesterol/sangre , Finlandia/epidemiología , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Humanos , Hipertrigliceridemia/sangre , Hipertrigliceridemia/etnología , Indígenas Norteamericanos/genética , Modelos Lineales , Lipoproteínas IDL/sangre , Lipoproteínas LDL/sangre , Lipoproteínas VLDL/sangre , Masculino , México/epidemiología , Persona de Mediana Edad , Tamaño de la Partícula , Linaje , Fenotipo , Medición de Riesgo , Factores de Riesgo , Triglicéridos/sangre , Población Blanca/genética
7.
HGG Adv ; 1(1)2020 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-33718894

RESUMEN

Attention deficit hyperactivity disorder (ADHD) is a common and highly heritable neurodevelopmental disorder with poorly understood pathophysiology and genetic mechanisms. A balanced chromosomal translocation interrupts CTNND2 in several members of a family with profound attentional deficit and myopia, and disruption of the gene was found in a separate unrelated individual with ADHD and myopia. CTNND2 encodes a brain-specific member of the adherens junction complex essential for postsynaptic and dendritic development, a site of potential pathophysiology in attentional disorders. Therefore, we propose that the severe and highly penetrant nature of the ADHD phenotype in affected individuals identifies CTNND2 as a potential gateway to ADHD pathophysiology similar to the DISC1 translocation in psychosis or AUTS2 in autism.

8.
Nat Commun ; 9(1): 3472, 2018 08 22.
Artículo en Inglés | MEDLINE | ID: mdl-30135520

RESUMEN

In the original version of this Article, Supplementary Table 10 contained incorrect primer sequences for the mobility shift assay for SNP rs4776984. These errors have now been fixed and the corrected version of the Supplementary Information PDF is available to download from the HTML version of the Article.

9.
Nat Commun ; 9(1): 1512, 2018 04 17.
Artículo en Inglés | MEDLINE | ID: mdl-29666371

RESUMEN

Increased adiposity is a hallmark of obesity and overweight, which affect 2.2 billion people world-wide. Understanding the genetic and molecular mechanisms that underlie obesity-related phenotypes can help to improve treatment options and drug development. Here we perform promoter Capture Hi-C in human adipocytes to investigate interactions between gene promoters and distal elements as a transcription-regulating mechanism contributing to these phenotypes. We find that promoter-interacting elements in human adipocytes are enriched for adipose-related transcription factor motifs, such as PPARG and CEBPB, and contribute to heritability of cis-regulated gene expression. We further intersect these data with published genome-wide association studies for BMI and BMI-related metabolic traits to identify the genes that are under genetic cis regulation in human adipocytes via chromosomal interactions. This integrative genomics approach identifies four cis-eQTL-eGene relationships associated with BMI or obesity-related traits, including rs4776984 and MAP2K5, which we further confirm by EMSA, and highlights 38 additional candidate genes.


Asunto(s)
Adipocitos/metabolismo , Adiposidad/genética , Cromosomas Humanos/genética , Predisposición Genética a la Enfermedad , Obesidad/genética , Tejido Adiposo/citología , Anciano , Índice de Masa Corporal , Células Cultivadas , Estudios de Cohortes , Finlandia , Regulación de la Expresión Génica/fisiología , Biblioteca de Genes , Redes Reguladoras de Genes/fisiología , Genómica/métodos , Humanos , Masculino , Persona de Mediana Edad , Obesidad/metabolismo , Fenotipo , Polimorfismo de Nucleótido Simple , Cultivo Primario de Células , Regiones Promotoras Genéticas/genética , Sitios de Carácter Cuantitativo/genética
10.
Atherosclerosis ; 264: 58-66, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28772107

RESUMEN

BACKGROUND AND AIMS: Hypercholesterolemia confers susceptibility to cardiovascular disease (CVD). Both serum total cholesterol (TC) and LDL-cholesterol (LDL-C) exhibit a strong genetic component (heritability estimates 0.41-0.50). However, a large part of this heritability cannot be explained by the variants identified in recent extensive genome-wide association studies (GWAS) on lipids. Our aim was to find genetic causes leading to high LDL-C levels and ultimately CVD in a large Austrian family presenting with what appears to be autosomal dominant inheritance for familial hypercholesterolemia (FH). METHODS: We utilized linkage analysis followed by whole-exome sequencing and genetic risk score analysis using an Austrian multi-generational family with various dyslipidemias, including elevated TC and LDL-C, and one family branch with elevated lipoprotein (a) (Lp(a)). RESULTS: We did not find evidence for genome-wide significant linkage for LDL-C or apparent causative variants in the known FH genes rather, we discovered a particular family-specific combination of nine GWAS LDL-C SNPs (p = 0.02 by permutation), and putative less severe familial hypercholesterolemia mutations in the LDLR and APOB genes in a subset of the affected family members. Separately, high Lp(a) levels observed in one branch of the family were explained primarily by the LPA locus, including short (<23) Kringle IV repeats and rs3798220. CONCLUSIONS: Taken together, some forms of FH may be explained by family-specific combinations of LDL-C GWAS SNPs.


Asunto(s)
Colesterol/sangre , Hiperlipoproteinemia Tipo II/genética , Mutación , Polimorfismo de Nucleótido Simple , Apolipoproteína B-100/genética , Austria , Biomarcadores/sangre , Análisis Mutacional de ADN , Femenino , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Herencia , Humanos , Hiperlipoproteinemia Tipo II/sangre , Hiperlipoproteinemia Tipo II/diagnóstico , Lipoproteína(a)/sangre , Lipoproteína(a)/genética , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Receptores de LDL/genética , Factores de Riesgo , Secuenciación del Exoma
11.
Obesity (Silver Spring) ; 24(10): 2033-7, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27515906

RESUMEN

OBJECTIVE: Multiple obesity susceptibility loci have been identified by genome-wide association studies, yet the mechanisms by which these loci influence obesity remain unclear. Alternative splicing could contribute to obesity by regulating the transcriptomic and proteomic diversity of genes in these loci. METHODS: Based on a database search, 72 of the 136 genes at the 13 obesity loci encoded multiple protein isoforms. Thus, alternative splicing of these genes in adipose tissue samples was analyzed from the Metabolic Syndrome in Men population-based study and from two weight loss intervention studies (surgical and very low calorie diet). RESULTS: Alternative splicing was confirmed in 11 genes with PCR capillary electrophoresis in human subcutaneous adipose tissue. Interestingly, differential splicing of TRA2B, BAG6, and MSH5 was observed between lean individuals with normoglycemia and overweight individuals with type 2 diabetes. Of these genes, we detected fat depot-dependent splicing of TRA2B and BAG6 and weight loss-induced regulation of MSH5 splicing in the intervention studies. Finally, body mass index was a major determinant of TRA2B, BAG6, and MSH5 splicing in the combined data. CONCLUSIONS: This study provides evidence for alternative splicing in obesity loci, suggesting that alternative splicing at least in part mediates the obesity-associated risk in these loci.


Asunto(s)
Resistencia a la Insulina/genética , Obesidad/genética , Receptor de Insulina/metabolismo , Grasa Subcutánea/metabolismo , Tejido Adiposo/metabolismo , Empalme Alternativo , Índice de Masa Corporal , Diabetes Mellitus Tipo 2/metabolismo , Femenino , Estudio de Asociación del Genoma Completo , Humanos , Masculino , Persona de Mediana Edad , Obesidad/metabolismo , Proteómica
12.
Nat Genet ; 48(3): 245-52, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26854917

RESUMEN

Many genetic variants influence complex traits by modulating gene expression, thus altering the abundance of one or multiple proteins. Here we introduce a powerful strategy that integrates gene expression measurements with summary association statistics from large-scale genome-wide association studies (GWAS) to identify genes whose cis-regulated expression is associated with complex traits. We leverage expression imputation from genetic data to perform a transcriptome-wide association study (TWAS) to identify significant expression-trait associations. We applied our approaches to expression data from blood and adipose tissue measured in ∼ 3,000 individuals overall. We imputed gene expression into GWAS data from over 900,000 phenotype measurements to identify 69 new genes significantly associated with obesity-related traits (BMI, lipids and height). Many of these genes are associated with relevant phenotypes in the Hybrid Mouse Diversity Panel. Our results showcase the power of integrating genotype, gene expression and phenotype to gain insights into the genetic basis of complex traits.


Asunto(s)
Regulación de la Expresión Génica/genética , Obesidad/genética , Sitios de Carácter Cuantitativo/genética , Transcriptoma/genética , Animales , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Genotipo , Humanos , Ratones , Obesidad/patología , Fenotipo
13.
Circ Cardiovasc Genet ; 7(4): 491-504, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24871327

RESUMEN

BACKGROUND: Low levels of high-density lipoprotein (HDL) cholesterol constitutes a major risk factor for atherosclerosis. Recent studies from our group reported a genetic association between the WW domain-containing oxidoreductase (WWOX) gene and HDL cholesterol levels. Here, through next-generation resequencing, in vivo functional studies and gene microarray analyses, we investigated the role of WWOX in HDL and lipid metabolism. METHODS AND RESULTS: Using next-generation resequencing of the WWOX region, we first identified 8 variants significantly associated and perfectly segregating with the low-HDL trait in 2 multigenerational French Canadian dyslipidemic families. To understand in vivo functions of WWOX, we used liver-specific Wwox(hep-/-) and total Wwox(-/-) mice models, where we found decreased ApoA-I and Abca1 levels in hepatic tissues. Analyses of lipoprotein profiles in Wwox(-/-), but not Wwox(hep-/-) littermates, also showed marked reductions in serum HDL cholesterol concentrations, concordant with the low-HDL findings observed in families. We next obtained evidence of a sex-specific effect in female Wwox(hep-/-) mice, where microarray analyses revealed an increase in plasma triglycerides and altered lipid metabolic pathways. We further identified a significant reduction in ApoA-I and Lpl and an upregulation in Fas, Angptl4, and Lipg, suggesting that the effects of Wwox involve multiple pathways, including cholesterol homeostasis, ApoA-I/ABCA1 pathway, and fatty acid biosynthesis/triglyceride metabolism. CONCLUSIONS: Our data indicate that WWOX disruption alters HDL and lipoprotein metabolism through several mechanisms and may account for the low-HDL phenotype observed in families expressing the WWOX variants. These findings thus describe a novel gene involved in cellular lipid homeostasis, which effects may impact atherosclerotic disease development.


Asunto(s)
Metabolismo de los Lípidos/fisiología , Lipoproteínas HDL/sangre , Oxidorreductasas/genética , Proteínas Supresoras de Tumor/genética , Transportador 1 de Casete de Unión a ATP/metabolismo , Adolescente , Adulto , Anciano , Alelos , Proteína 4 Similar a la Angiopoyetina , Angiopoyetinas/metabolismo , Animales , Apolipoproteína A-I/metabolismo , HDL-Colesterol/sangre , Cromosomas Humanos Par 16 , Femenino , Haplotipos , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Lipasa/metabolismo , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Persona de Mediana Edad , Oxidorreductasas/deficiencia , Oxidorreductasas/metabolismo , Polimorfismo de Nucleótido Simple , Análisis de Secuencia de ADN , Triglicéridos/sangre , Proteínas Supresoras de Tumor/metabolismo , Regulación hacia Arriba , Oxidorreductasa que Contiene Dominios WW , Receptor fas/metabolismo
14.
Nat Commun ; 5: 3983, 2014 Jun 02.
Artículo en Inglés | MEDLINE | ID: mdl-24886709

RESUMEN

Dyslipidemia and obesity are especially prevalent in populations with Amerindian backgrounds, such as Mexican-Americans, which predispose these populations to cardiovascular disease. Here we design an approach, known as the cross-population allele screen (CPAS), which we conduct prior to a genome-wide association study (GWAS) in 19,273 Europeans and Mexicans, in order to identify Amerindian risk genes in Mexicans. Utilizing CPAS to restrict the GWAS input variants to only those differing in frequency between the two populations, we identify novel Amerindian lipid genes, receptor-related orphan receptor alpha (RORA) and salt-inducible kinase 3 (SIK3), and three loci previously unassociated with dyslipidemia or obesity. We also detect lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) harbouring specific Amerindian signatures of risk variants and haplotypes. Notably, we observe that SIK3 and one novel lipid locus underwent positive selection in Mexicans. Furthermore, after a high-fat meal, the SIK3 risk variant carriers display high triglyceride levels. These findings suggest that Amerindian-specific genetic architecture leads to a higher incidence of dyslipidemia and obesity in modern Mexicans.


Asunto(s)
Hipercolesterolemia/genética , Hipertrigliceridemia/genética , Indígenas Norteamericanos/genética , Obesidad/genética , Adulto , Apolipoproteína A-V , Apolipoproteínas A/genética , Estudios de Casos y Controles , Cromosomas Humanos Par 11/genética , Cromosomas Humanos Par 8/genética , Dislipidemias/genética , Femenino , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Genotipo , Haplotipos , Humanos , Lipoproteína Lipasa/genética , Modelos Logísticos , Masculino , México/etnología , Persona de Mediana Edad , Miembro 1 del Grupo F de la Subfamilia 1 de Receptores Nucleares/genética , Polimorfismo de Nucleótido Simple , Proteínas Quinasas/genética , Población Blanca/genética , Adulto Joven
15.
BMC Med Genomics ; 5: 61, 2012 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-23217153

RESUMEN

BACKGROUND: High serum triglyceride (TG) levels is an established risk factor for coronary heart disease (CHD). Fat is stored in the form of TGs in human adipose tissue. We hypothesized that gene co-expression networks in human adipose tissue may be correlated with serum TG levels and help reveal novel genes involved in TG regulation. METHODS: Gene co-expression networks were constructed from two Finnish and one Mexican study sample using the blockwiseModules R function in Weighted Gene Co-expression Network Analysis (WGCNA). Overlap between TG-associated networks from each of the three study samples were calculated using a Fisher's Exact test. Gene ontology was used to determine known pathways enriched in each TG-associated network. RESULTS: We measured gene expression in adipose samples from two Finnish and one Mexican study sample. In each study sample, we observed a gene co-expression network that was significantly associated with serum TG levels. The TG modules observed in Finns and Mexicans significantly overlapped and shared 34 genes. Seven of the 34 genes (ARHGAP30, CCR1, CXCL16, FERMT3, HCST, RNASET2, SELPG) were identified as the key hub genes of all three TG modules. Furthermore, two of the 34 genes (ARHGAP9, LST1) reside in previous TG GWAS regions, suggesting them as the regional candidates underlying the GWAS signals. CONCLUSIONS: This study presents a novel adipose gene co-expression network with 34 genes significantly correlated with serum TG across populations.


Asunto(s)
Tejido Adiposo/metabolismo , Regulación de la Expresión Génica , Redes Reguladoras de Genes/genética , Triglicéridos/genética , Estudios de Casos y Controles , Finlandia , Perfilación de la Expresión Génica , Sitios Genéticos/genética , Estudio de Asociación del Genoma Completo , Humanos , Inmunidad/genética , Inflamación/sangre , Inflamación/genética , México , Polimorfismo de Nucleótido Simple/genética , Triglicéridos/sangre , Gemelos/genética
16.
Circ Cardiovasc Genet ; 5(5): 538-46, 2012 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-22923419

RESUMEN

BACKGROUND: Exome sequencing is a recently implemented method to discover rare mutations for Mendelian disorders. Less is known about its feasibility to identify genes for complex traits. We used exome sequencing to search for rare variants responsible for a complex trait, low levels of serum high-density lipoprotein cholesterol (HDL-C). METHODS AND RESULTS: We conducted exome sequencing in a large French-Canadian family with 75 subjects available for study, of which 27 had HDL-C values less than the fifth age-sex-specific population percentile. We captured ≈50 Mb of exonic and transcribed sequences of 3 closely related family members with HDL-C levels less than the fifth age-sex percentile and sequenced the captured DNA. Approximately 82,000 variants were detected in each individual, of which 41 rare nonsynonymous variants were shared by the sequenced affected individuals after filtering steps. Two rare nonsynonymous variants in the ATP-binding cassette, subfamily A (ABC1), member 1 (ABCA1), and lipoprotein lipase genes predicted to be damaging were investigated for cosegregation with the low HDL-C trait in the entire extended family. The carriers of either variant had low HDL-C levels, and the individuals carrying both variants had the lowest HDL-C values. Interestingly, the ABCA1 variant exhibited a sex effect which was first functionally identified, and, subsequently, statistically demonstrated using additional French-Canadian families with ABCA1 mutations. CONCLUSIONS: This complex combination of 2 rare variants causing low HDL-C in the extended family would not have been identified using traditional linkage analysis, emphasizing the need for exome sequencing of complex lipid traits in unexplained familial cases.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , LDL-Colesterol/genética , Exoma/genética , Lipoproteína Lipasa/genética , Transportador 1 de Casete de Unión a ATP , Transportadoras de Casetes de Unión a ATP/metabolismo , Alelos , Células Cultivadas , LDL-Colesterol/metabolismo , Familia , Ligamiento Genético , Genoma Humano , Genotipo , Humanos , Lipoproteína Lipasa/metabolismo , Mutación Missense , Análisis de Secuencia de ADN , Factores Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA